February 23, 2022 Comments Off on New patent for Gilead Sciences drug VEKLURY Posted in: Patent Added Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent for Gilead Sciences drug VEKLURY appeared first on DrugPaten…
February 23, 2022 Comments Off on New patent for Intercept Pharms drug OCALIVA Posted in: Patent Added Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Intercept Pharms drug OCALIVA appeared first on DrugPate…
